A ceremony was recently staged by the Peking University Medical School and the University of Michigan Medical School to celebrate the first anniversary of the Institute for Translational Medicine jointly established by the two universities, along with the opening of a translational medicine seminar. At the four-day seminar, Chinese and American scientists exchanged views on a range of topics, including cardiovascular diseases, metabolic diseases among others.
The Peking University Medical School and the University of Michigan Medical School established in 2010 an Institute for translational medicine, in a bid to raise the research level in the area. Each party contributed USD 7 million to finance the most promising projects that work on the cutting-edge topics, in an attempt to land major breakthroughs in dealing with some sophisticated diseases. In the past year, the Institute has made laudable progresses in establishing six joint research projects concerning viral hepatitis, obesity, hypertension, coronary artery disease, lung disease, and smoking. Meanwhile, the Institute has created an Ethics Review Committee, and plans to establish a biomedical information platform that takes care of samples and data collection and management.